Discovery of CP-866,087, a mu opioid receptor antagonist for the treatment of alcohol abuse and dependence

被引:21
作者
McHardy, Stanton F. [1 ]
Heck, Steven D. [1 ]
Guediche, Sara [1 ]
Kalman, Monica [1 ]
Allen, Martin P. [1 ]
Tu, Meihua [1 ]
Bryce, Dianne K. [2 ]
Schmidt, Anne W. [2 ]
Vanase-Frawley, Michelle [2 ]
Callegari, Ernesto [3 ]
Doran, Shawn [3 ]
Grahame, Nicholas J. [4 ]
McLean, Stafford [2 ]
Liras, Spiros [1 ]
机构
[1] Pfizer Inc, Worldwide Res & Dev, Worldwide Med Chem, Groton, CT 06340 USA
[2] Pfizer Inc, Worldwide Res & Dev, Neurosci Biol, Groton, CT 06340 USA
[3] Pfizer Inc, Worldwide Res & Dev, Pharmacokinet Dynam & Metab, Groton, CT 06340 USA
[4] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
关键词
CYTOCHROME-P450; 2D6; DRUG; METABOLISM; PATHWAYS;
D O I
10.1039/c1md00164g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CP-866,087 (compound 15) is a novel, potent and selective mu opioid receptor antagonist. The design rationale, synthesis, in vitro and in vivo biological evaluation are reported herein. Preclinical efficacy data in disease relevant models measuring reduction of alcohol intake are presented, along with preclinical pharmacokinetic properties which supported the selection of the title compound for clinical evaluation.
引用
收藏
页码:1001 / 1005
页数:5
相关论文
共 30 条
[1]  
Banks B. J., 2003, U.S. Pat. Appl. Publ., Patent No. [US 20030207876, 20030207876]
[2]  
Brunijnzeel A. W., 2009, BRAIN RES REV, V62, P127
[3]   The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption [J].
Cowen, MS ;
Lawrence, AJ .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1999, 23 (07) :1171-1212
[4]  
Diaz Gilbert J., 2004, Journal of Pharmacological and Toxicological Methods, V50, P187, DOI 10.1016/j.vascn.2004.04.001
[5]   Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers [J].
Drobes, DJ ;
Anton, RF ;
Thomas, SE ;
Voronin, K .
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (09) :1362-1370
[6]   [3H]dofetilide binding to HERG transfected membranes:: a potential high throughput preclinical screen [J].
Finlayson, K ;
Turnbull, L ;
January, CT ;
Sharkey, J ;
Kelly, JS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 430 (01) :147-148
[7]   Membrane transporters in drug development [J].
Giacomini, Kathleen M. ;
Huang, Shiew-Mei ;
Tweedie, Donald J. ;
Benet, Leslie Z. ;
Brouwer, Kim L. R. ;
Chu, Xiaoyan ;
Dahlin, Amber ;
Evers, Raymond ;
Fischer, Volker ;
Hillgren, Kathleen M. ;
Hoffmaster, Keith A. ;
Ishikawa, Toshihisa ;
Keppler, Dietrich ;
Kim, Richard B. ;
Lee, Caroline A. ;
Niemi, Mikko ;
Polli, Joseph W. ;
Sugiyama, Yuicchi ;
Swaan, Peter W. ;
Ware, Joseph A. ;
Wright, Stephen H. ;
Yee, Sook Wah ;
Zamek-Gliszczynski, Maciej J. ;
Zhang, Lei .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (03) :215-236
[8]   Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches [J].
Hosea, Natilie A. ;
Collard, Wendy T. ;
Cole, Susan ;
Maurer, Tristan S. ;
Fang, Rick X. ;
Jones, Hannah ;
Kakar, Shefali M. ;
Nakai, Yasuhiro ;
Smith, Bill J. ;
Webster, Rob ;
Beaumont, Kevin .
JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (05) :513-533
[9]   Physiochemical drug properties associated with in vivo toxicological outcomes [J].
Hughes, Jason D. ;
Blagg, Julian ;
Price, David A. ;
Bailey, Simon ;
DeCrescenzo, Gary A. ;
Devraj, Rajesh V. ;
Ellsworth, Edmund ;
Fobian, Yvette M. ;
Gibbs, Michael E. ;
Gilles, Richard W. ;
Greene, Nigel ;
Huang, Enoch ;
Krieger-Burke, Teresa ;
Loesel, Jens ;
Wager, Travis ;
Whiteley, Larry ;
Zhang, Yao .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) :4872-4875
[10]   A CERIUM(III) MODIFICATION OF THE PETERSON REACTION - METHYLENATION OF READILY ENOLIZABLE CARBONYL-COMPOUNDS [J].
JOHNSON, CR ;
TAIT, BD .
JOURNAL OF ORGANIC CHEMISTRY, 1987, 52 (02) :281-283